Search research articles
Contact Us
Filters
Showing results (11-20 of 117) with videos related to
Page
of 12
Sort By:
Acta Paediatrica (Oslo, Norway : 1992). Supplement
|
May 25, 2006
Damage at the cellular and organ levels in LSDs: possibility for prevention/reversibility with ERT
Timothy M Cox, Michael Beck
Molecular Genetics and Metabolism Reports
|
November 6, 2019
Comment: Why are females with Fabry disease affected?
Michael Beck, Timothy M Cox
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 20, 2005
Hemochromatosis: genetic testing and clinical practice
Heinz Zoller, Timothy M Cox
Blood Cells, Molecules & Diseases
|
January 26, 2017
Roscoe O. Brady: Physician whose pioneering discoveries in lipid biochemistry revolutionized treatment and understanding of lysosomal diseases
Johannes M Aerts, Timothy M Cox
Drug Design, Development and Therapy
|
May 8, 2012
Imiglucerase in the treatment of Gaucher disease: a history and perspective
Patrick B Deegan, Timothy M Cox
Expert Reviews in Molecular Medicine
|
May 11, 2016
Editorial
Julian E Sale, Timothy M Cox
Blood Cells, Molecules & Diseases
|
December 1, 2017
Therapeutic position of eliglustat
Timothy M Cox, Pramod K Mistry
Blood Cells, Molecules & Diseases
|
January 28, 2003
Hemochromatosis--neonatal and young subjects
Timothy M Cox, David J Halsall
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 31, 2003
Tartrate-resistant acid phosphatase knockout mice
Alison R Hayman, Timothy M Cox
Cell Biochemistry and Function
|
September 1, 2004
Tartrate-resistant acid phosphatase: a potential target for therapeutic gold
Alison R Hayman, Timothy M Cox
Page
of 12
Search research articles
Search
Showing results (11-20 of 117) with videos related to
Sort By:
Page
of 12
Acta Paediatrica (Oslo, Norway : 1992). Supplement
|
May 25, 2006
Damage at the cellular and organ levels in LSDs: possibility for prevention/reversibility with ERT
Timothy M Cox, Michael Beck
Molecular Genetics and Metabolism Reports
|
November 6, 2019
Comment: Why are females with Fabry disease affected?
Michael Beck, Timothy M Cox
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 20, 2005
Hemochromatosis: genetic testing and clinical practice
Heinz Zoller, Timothy M Cox
Blood Cells, Molecules & Diseases
|
January 26, 2017
Roscoe O. Brady: Physician whose pioneering discoveries in lipid biochemistry revolutionized treatment and understanding of lysosomal diseases
Johannes M Aerts, Timothy M Cox
Drug Design, Development and Therapy
|
May 8, 2012
Imiglucerase in the treatment of Gaucher disease: a history and perspective
Patrick B Deegan, Timothy M Cox
Expert Reviews in Molecular Medicine
|
May 11, 2016
Editorial
Julian E Sale, Timothy M Cox
Blood Cells, Molecules & Diseases
|
December 1, 2017
Therapeutic position of eliglustat
Timothy M Cox, Pramod K Mistry
Blood Cells, Molecules & Diseases
|
January 28, 2003
Hemochromatosis--neonatal and young subjects
Timothy M Cox, David J Halsall
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 31, 2003
Tartrate-resistant acid phosphatase knockout mice
Alison R Hayman, Timothy M Cox
Cell Biochemistry and Function
|
September 1, 2004
Tartrate-resistant acid phosphatase: a potential target for therapeutic gold
Alison R Hayman, Timothy M Cox
Page
of 12